reviewNeurologyMay 5, 2008BRONZE OA

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) [RETIRED]

University of Kansas · St. Luke's-Roosevelt Hospital Center · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Objective

To perform an evidence-based review of the safety and efficacy of botulinum neurotoxin (BoNT) in the treatment of movement disorders.

Methods

A literature search was performed including MEDLINE and Current Contents for therapeutic articles relevant to BoNT and selected movement disorders. Authors reviewed, abstracted, and classified articles based on American Academy of Neurology criteria (Class I-IV).

Citation impact

618
total citations
FWCI
37.32
Percentile
100%
References
84
Citations per year

Authors

12

Topics & keywords

Keywords
  • Blepharospasm
  • Hemifacial spasm
  • Dystonia
  • Cervical dystonia
  • Botulinum toxin
  • Focal dystonia
  • Medicine
  • Botulinum neurotoxin
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.